Bone in CKD Alkali Response (BICARb) Trial
Phase 2/3
103
about 2 years
5–100
2 sites in NY, PA
What this study is about
Researchers are testing whether potassium citrate improves bone health in people with chronic kidney disease. The trial will compare the effects of potassium citrate to a placebo on bone quality and strength, as well as investigate how potassium citrate affects bones. Participants will provide blood samples and undergo advanced bone imaging during it.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take Potassium Citrate Extended Release Oral Tablet
- 3.Take Potassium Citrate and Citric Acid Oral Solution
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
ALIMENTARY TRACT AND METABOLISM, potassium citrate
topical, oral (Oral Capsule), oral
Renal, Musculoskeletal